参考文献/References:
[1]Artunc F,Schleicher E,Weigert C,et al.The impact of insulin resistance on the kidney and vasculature[J].Nat Rev Nephrol,2016,12(12):721-737. [2]Singh S,Sharma R,Kumari M,et al.Insulin receptors in the kidneys in health and disease[J].World J Nephrol,2019,8(1):11-22. [3]Conte C,Epstein S,Napoli N.Insulin resistance and bone: a biological partnership[J].Acta Diabetol,2018,55(4):305-314. [4]Lay AC,Hurcombe JA,Betin VMS,et al.Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor[J].Diabetologia,2017,60(11):2299-2311. [5]Garner KL,Betin VMS,Pinto V,et al.Enhanced insulin receptor, but not PI3K, signalling protects podocytes from ER stress[J].Sci Rep,2018,8(1):3902. [6]Rogacka D,Piwkowska A,Audzeyenka I,et al.SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes[J].Exp Cell Res, 2016,349(2):328-338. [7]Rogacka D,Audzeyenka I,Rych?owski M,et al.Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(1):115-125. [8]Yang D,Livingston MJ,Liu Z,et al.Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential[J].Cell Mol Life Sci,2018,75(4):669-688. [9]Polianskyte-Prause Z,Tolvanen TA,Lindfors S,et al.Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity[J].FASEB J,2019,33(2):2858-2869. [10]Rogacka D,Piwkowska A,Audzeyenka I,et al.Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes[J].Int J Biochem Cell Biol,2014(51):120-130. [11]Garner KL,Betin VMS,Pinto V,et al.Enhanced insulin receptor, but not PI3K, signalling protects podocytes from ER stress[J].Sci Rep,2018,8(1):3902. [12]Geraldes P.Protein phosphatases and podocyte function[J].Curr Opin Nephrol Hypertens,2018,27(1):49-55. [13]Ito Y,Hsu MF,Bettaieb A,et al.Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury[J].Metabolism,2017(76):56-69. [14]Matulewicz N,Karczewska-Kupczewska M.Insulin resistance and chronic inflammation[J].Postepy Hig Med Dosw (Online),2016(70):1245-1258. [15]Du P,Fan B,Han H,et al.NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy[J].Kidney Int,2013,84(2):265-276. [16]Mohamed R,Jayakumar C,Chen F,et al.Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis[J].J Am Soc Nephrol,2016,27(3):745-765. [17]Levine B,Ranganathan R.Autophagy: Snapshot of the network[J].Nature,2010,466(7302):38-40. [18]Xu Y,Zhou Q,Xin W,et al.Autophagy downregulation contributes to insulin resistance mediated injury in insulin receptor knockout podocytes in vitro[J].Peer J,2016(4):e1888. [19]Xin W,Li Z,Xu Y,et al.Autophagy protects human podocytes from high glucose-induced injury by preventing insulin resistance[J].Metabolism,2016,65(9):1307-1315. [20]Audzeyenka I,Rogacka D,Piwkowska A,et al.Viability of primary cultured podocytes is associated with extracellular highglucose-dependent autophagy downregulation[J].Mol Cell Biochem,2017,430(1-2):11-19. [21]Zhan X,Yan C,Chen Y,et al.Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway[J].Mol Immunol,2018(104):61-68. [22]Hurcombe JA,Lay AC,Ni L,et al.Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function[J].FASEB Bioadv,2019,1(8):498-510. [23]Cao AL,Wang L,Chen X,et al.Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy[J].Lab Invest,2016,96(6):610-622. [24]Li Z,Yuan Y,Meng Y,et al.Autophagy upregulation ameliorates cell injury in Sequestosome 1 knockout podocytes in vitro[J].Biochem Biophys Res Commun,2017,490(2):98-103. [25]Carlsson AC,Calamia M,Risérus U,et al.Kidney injury molecule (KIM)-1 is associated with insulin resistance: results from two community-based studies of elderly individuals[J].Diabetes Res Clin Pract,2014,103(3):516-521. [26]Kumari M,Sharma R,Pandey G,et al.Deletion of insulin receptor in the proximal tubule and fasting augment albumin excretion[J].J Cell Biochem,2019,120(6):10688-10696. [27]Zhang Y,Yang S,Cui X,et al.Hyperinsulinemia Can Cause Kidney Disease in the IGT Stage of OLETF Rats via the INS/IRS-1/PI3-K/Akt Signaling Pathway[J].J Diabetes Res,2019(2019):4709715. [28]Nizar JM,Shepard BD,Vo VT,et al.Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption[J].JCI Insight,2018,3(16):e95107. [29]Nakamura M,Yamazaki O,Shirai A, et al.Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome[J].Kidney Int,2015,87(3):535-542. [30]Zheng Y,Yamada H,Sakamoto K,et al.Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption[J].J Am Soc Nephrol,2005,16(8):2288-2295. [31]Tanaka M.Improving obesity and blood pressure[J].Hypertens Res,2020,43(2):79-89. [32]Pandey G,Makhija E,George N,et al.Insulin regulates nitric oxide production in the kidney collecting duct cells[J].J Biol Chem,2015,290(9):5582-5591. [33]Asplin JR.Uric acid stones[J].Semin Nephrol,1996,16(5):412-424. [34]Spatola L,Angelini C,Badalamenti S,et al.Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences[J].Urolithiasis,2017,45(5):457-460. [35]Ichida K.[Hyperuricemia and metabolic syndrome][J].Nihon Yakurigaku Zasshi,2010,136(6):321-324. [36]于艳,何丽洁,王汉民.NLRP1炎性体促进高糖高胰岛素诱导的肾小球系膜细胞焦亡[J].细胞与分子免疫学杂志,2018,34(5):442-447. [37]Subathra M,Korrapati M,Howell LA,et al.Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells[J].Am J Physiol Renal Physiol,2015,309(3):F204-F215. [38]Xu WW,Guan MP,Zheng ZJ,et al.Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the AMPK pathway[J].Cell Physiol Biochem,2014,33(2):423-432. [39]Horita S,Nakamura M,Suzuki M,et al.Selective Insulin Resistance in the Kidney[J].Biomed Res Int,2016(2016):5825170. [40]Mima A,Ohshiro Y,Kitada M,et al.Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity[J].Kidney Int,2011,79(8):883-896. [41]Sarafidis PA,Lasaridis AN.Insulin Resistance and Endothelin: Another Pathway for Renal Injury in Patients With the Cardiometabolic Syndrome?[J].Journal of the Cardio Metabolic Syndrome,2008,3(3):183-187.
相似文献/References:
[1]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Medical Information,2018,31(24):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[2]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(24):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[3]王清华,易守芳,余明芳.肾移植术后药源性肾损伤生物标志物的研究[J].医学信息,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
WANG Qing-hua,YI Shou-fang,YU Ming-fang.Study on Biomarkers of Drug-induced Renal Injury after Renal Transplantation[J].Medical Information,2019,32(24):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
[4]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、
白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and
Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Medical Information,2019,32(24):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[5]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系
及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with
Lower Urinary Tract Symptoms and Treatment[J].Medical Information,2019,32(24):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
[6]赵 猛,孙 娟,褚 璇.苯扎贝特改善2型糖尿病合并高甘油三酯血症患者
胰岛素抵抗的临床分析[J].医学信息,2019,32(17):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
ZHAO Meng,SUN Juan,CHU Xuan.Clinical Analysis of Bezafibrate in Improving Insulin Resistance in Patients with
Type 2 Diabetes Mellitus Complicated with Hypertriglyceridemia[J].Medical Information,2019,32(24):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
[7]李淑娟,王爱芹,杨学军,等.子宫内膜息肉发病相关危险因素临床分析[J].医学信息,2019,32(13):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
LI Shu-juan,WANG Ai-qin,YANG Xue-jun,et al.Clinical Analysis of Risk Factors Related to the Incidence of Endometrial Polyps[J].Medical Information,2019,32(24):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
[8]陈 月,任 伟.胰岛素抵抗与肌少症关系的研究[J].医学信息,2019,32(23):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
CHEN Yue,REN Wei.Study on the Relationship Between Insulin Resistance and Sarcopenia[J].Medical Information,2019,32(24):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
[9]李 玲,宋光耀.健康体检者胰岛素抵抗与血脂异常的相关性及血脂最佳分界值的探讨[J].医学信息,2020,33(01):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]
LI Ling,SONG Guang-yao.Correlation Between Insulin Resistance and Dyslipidemia and the Best Cut-off Value of Blood Lipids in Healthy People[J].Medical Information,2020,33(24):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]
[10]张晴晴,张瑞霞.Irisin的生理效应及其循环水平的影响因素[J].医学信息,2020,33(02):36.[doi:10.3969/j.issn.1006-1959.2020.02.010]
ZHANG Qing-qing,ZHANG Rui-xia.The Physiological Effect of Irisin and the Influencing Factors of its Circulation Level[J].Medical Information,2020,33(24):36.[doi:10.3969/j.issn.1006-1959.2020.02.010]